Publications

2023

Curvino, Elizabeth J., Emily F. Roe, Helena Freire Haddad, Alexa R. Anderson, Mia E. Woodruff, Nicole L. Votaw, Tatiana Segura, Laura P. Hale, and Joel H. Collier. “Engaging natural antibody responses for the treatment of inflammatory bowel disease via phosphorylcholine-presenting nanofibres.” Nat Biomed Eng, November 27, 2023. https://doi.org/10.1038/s41551-023-01139-6.

Lazar, K. M., S. Shetty, A. Chilkoti, and J. H. Collier. “Immune-active polymeric materials for the treatment of inflammatory diseases.” Current Opinion in Colloid and Interface Science 67 (October 1, 2023). https://doi.org/10.1016/j.cocis.2023.101726.

Si, Youhui, Yihan Wang, Qiaomu Tian, Qiang Wang, Jared M. Pollard, Pramod K. Srivastava, Aaron P. Esser-Kahn, Joel H. Collier, Anne I. Sperling, and Anita S. Chong. “Lung cDC1 and cDC2 dendritic cells priming naive CD8+ T cells in situ prior to migration to draining lymph nodes.” Cell Reports 42, no. 10 (October 2023): 113299. https://doi.org/10.1016/j.celrep.2023.113299.

Liu, Yining, Alejandra Suarez-Arnedo, Shamitha Shetty, Yaoying Wu, Michelle Schneider, Joel H. Collier, and Tatiana Segura. “A Balance between Pro-Inflammatory and Pro-Reparative Macrophages is Observed in Regenerative D-MAPS.” Advanced Science (Weinheim, Baden-Wurttemberg, Germany) 10, no. 11 (April 2023): e2204882. https://doi.org/10.1002/advs.202204882.

Ozer, Imran, Anna Slezak, Parul Sirohi, Xinghai Li, Nikita Zakharov, Yunxin Yao, Jeffrey I. Everitt, et al. “An injectable PEG-like conjugate forms a subcutaneous depot and enables sustained delivery of a peptide drug.” Biomaterials 294 (March 2023): 121985. https://doi.org/10.1016/j.biomaterials.2022.121985.

Freire Haddad, Helena, Emily F. Roe, and Joel H. Collier. “Expanding opportunities to engineer mucosal vaccination with biomaterials.” Biomaterials Science 11, no. 5 (February 2023): 1625–47. https://doi.org/10.1039/d2bm01694j.

2022

Kelly, Sean H., Nicole L. Votaw, Benjamin J. Cossette, Yaoying Wu, Shamitha Shetty, Lucas S. Shores, Luqman A. Issah, and Joel H. Collier. “A sublingual nanofiber vaccine to prevent urinary tract infections.” Science Advances 8, no. 47 (November 2022): eabq4120. https://doi.org/10.1126/sciadv.abq4120.

Chen, Jui-Lin, Chelsea N. Fries, Stella J. Berendam, Nicole S. Rodgers, Emily F. Roe, Yaoying Wu, Shuk Hang Li, et al. “Self-assembling peptide nanofiber HIV vaccine elicits robust vaccine-induced antibody functions and modulates Fc glycosylation.” Sci Adv 8, no. 38 (September 23, 2022): eabq0273. https://doi.org/10.1126/sciadv.abq0273.

Wu, Yaoying, Hanning Wen, Zachary J. Bernstein, Kelly M. Hainline, Tykia S. Blakney, Kendra L. Congdon, David J. Snyder, John H. Sampson, Luis Sanchez-Perez, and Joel H. Collier. “Multiepitope supramolecular peptide nanofibers eliciting coordinated humoral and cellular antitumor immune responses.” Sci Adv 8, no. 29 (July 22, 2022): eabm7833. https://doi.org/10.1126/sciadv.abm7833.

Ozer, Imran, Garrett Kelly, Renpeng Gu, Xinghai Li, Nikita Zakharov, Parul Sirohi, Smita K. Nair, et al. “Polyethylene Glycol-Like Brush Polymer Conjugate of a Protein Drug Does Not Induce an Antipolymer Immune Response and Has Enhanced Pharmacokinetics than Its Polyethylene Glycol Counterpart.” Adv Sci (Weinh) 9, no. 11 (April 2022): e2103672. https://doi.org/10.1002/advs.202103672.

2021

Fries, Chelsea N., Jui-Lin Chen, Maria L. Dennis, Nicole L. Votaw, Joshua Eudailey, Brian E. Watts, Kelly M. Hainline, et al. “HIV envelope antigen valency on peptide nanofibers modulates antibody magnitude and binding breadth.” Scientific Reports 11, no. 1 (July 2021): 14494. https://doi.org/10.1038/s41598-021-93702-x.

Votaw, Nicole L., Lauren Collier, Elizabeth J. Curvino, Yaoying Wu, Chelsea N. Fries, Madison T. Ojeda, and Joel H. Collier. “Randomized peptide assemblies for enhancing immune responses to nanomaterials.” Biomaterials 273 (June 2021): 120825. https://doi.org/10.1016/j.biomaterials.2021.120825.

Cossette, Benjamin, Sean H. Kelly, and Joel H. Collier. “Intranasal Subunit Vaccination Strategies Employing Nanomaterials and Biomaterials.” ACS Biomaterials Science & Engineering 7, no. 5 (May 2021): 1765–79. https://doi.org/10.1021/acsbiomaterials.0c01291.

Kelly, Sean H., Benjamin J. Cossette, Ajay K. Varadhan, Yaoying Wu, and Joel H. Collier. “Titrating Polyarginine into Nanofibers Enhances Cyclic-Dinucleotide Adjuvanticity in Vitro and after Sublingual Immunization.” ACS Biomaterials Science & Engineering 7, no. 5 (May 2021): 1876–88. https://doi.org/10.1021/acsbiomaterials.0c01429.

Fries, Chelsea N., Elizabeth J. Curvino, Jui-Lin Chen, Sallie R. Permar, Genevieve G. Fouda, and Joel H. Collier. “Advances in nanomaterial vaccine strategies to address infectious diseases impacting global health.” Nat Nanotechnol 16, no. 4 (April 2021): 1–14. https://doi.org/10.1038/s41565-020-0739-9.

Hainline, Kelly M., Lucas S. Shores, Nicole L. Votaw, Zachary J. Bernstein, Sean H. Kelly, Chelsea N. Fries, Marisha S. Madhira, Caslin A. Gilroy, Ashutosh Chilkoti, and Joel H. Collier. “Modular complement assemblies for mitigating inflammatory conditions.” Proceedings of the National Academy of Sciences of the United States of America 118, no. 15 (April 2021): e2018627118. https://doi.org/10.1073/pnas.2018627118.

Kelly, Sean H., Emmanuel E. Opolot, Yaoying Wu, Benjamin Cossette, Ajay K. Varadhan, and Joel H. Collier. “Tabletized Supramolecular Assemblies for Sublingual Peptide Immunization.” Advanced Healthcare Materials 10, no. 6 (March 2021): e2001614. https://doi.org/10.1002/adhm.202001614.

Ozer, Imran, Anna Slezak, Jeffrey Everitt, Xinghai Li, Nikita Zakharov, Joel Collier, Jonathan Campbell, David D’Alessio, and Ashutosh Chilkoti. “Injectable non-immunogenic PEG-like conjugate that forms a subcutaneous depot and enables sustained delivery of a peptide drug,” 2021. https://doi.org/10.21203/rs.3.rs-737658/v1.

2020

Fries, Chelsea N., Yaoying Wu, Sean H. Kelly, Michelle Wolf, Nicole L. Votaw, Stefan Zauscher, and Joel H. Collier. “Controlled Lengthwise Assembly of Helical Peptide Nanofibers to Modulate CD8+ T-Cell Responses.” Advanced Materials (Deerfield Beach, Fla.) 32, no. 39 (October 2020): e2003310. https://doi.org/10.1002/adma.202003310.

Si, Youhui, Qiaomu Tian, Fan Zhao, Sean H. Kelly, Lucas S. Shores, Daniel F. Camacho, Anne I. Sperling, Michael S. Andrade, Joel H. Collier, and Anita S. Chong. “Adjuvant-free nanofiber vaccine induces in situ lung dendritic cell activation and TH17 responses.” Science Advances 6, no. 32 (August 2020): eaba0995. https://doi.org/10.1126/sciadv.aba0995.

Wu, Yaoying, Sean H. Kelly, Luis Sanchez-Perez, John H. Sampson, and Joel H. Collier. “Comparative study of α-helical and β-sheet self-assembled peptide nanofiber vaccine platforms: influence of integrated T-cell epitopes.” Biomater Sci 8, no. 12 (June 21, 2020): 3522–35. https://doi.org/10.1039/d0bm00521e.

Kelly, Sean H., Yaoying Wu, Ajay K. Varadhan, Elizabeth J. Curvino, Anita S. Chong, and Joel H. Collier. “Enabling sublingual peptide immunization with molecular self-assemblies.” Biomaterials 241 (May 2020): 119903. https://doi.org/10.1016/j.biomaterials.2020.119903.

Shores, Lucas S., Sean H. Kelly, Kelly M. Hainline, Jutamas Suwanpradid, Amanda S. MacLeod, and Joel H. Collier. “Multifactorial Design of a Supramolecular Peptide Anti-IL-17 Vaccine Toward the Treatment of Psoriasis.” Front Immunol 11 (2020): 1855. https://doi.org/10.3389/fimmu.2020.01855.

2019

Nelson, Christopher, Yaoying Wu, Matthew Gemberling, Matthew Oliver, Joel D. Bohning, Jacqueline N. Robinson-Hamm, Karen Bulaklak, et al. “Long-Term Evaluation of AAV-CRISPR Genome Editing for Duchenne Muscular Dystrophy.” In MOLECULAR THERAPY, 27:46–47. CELL PRESS, 2019.

Nelson, Christopher E., Yaoying Wu, Matthew P. Gemberling, Matthew L. Oliver, Matthew A. Waller, Joel D. Bohning, Jacqueline N. Robinson-Hamm, et al. “Long-term evaluation of AAV-CRISPR genome editing for Duchenne muscular dystrophy.” Nat Med 25, no. 3 (March 2019): 427–32. https://doi.org/10.1038/s41591-019-0344-3.